Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001737287-21-000010
Filing Date
2021-02-25
Accepted
2021-02-25 17:02:15
Documents
4
Effectiveness Date
2021-02-25
Reference 429
333-236701

Document Format Files

Seq Description Document Type Size
1 S-8 allogene-formsx8x20210225.htm S-8 84925
2 EX-23.1 exhibit231-formsx8x20210225.htm EX-23.1 2700
3 EX-5.1 exhibit51-formsx8x20210225.htm EX-5.1 8763
4 cooley1.jpg GRAPHIC 10201
  Complete submission text file 0001737287-21-000010.txt   111625
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253530 | Film No.: 21681419
SIC: 2836 Biological Products, (No Diagnostic Substances)